Novartis Settles Kentucky Drug-Pricing Claims For $3M

Law360, Chicago (March 29, 2012, 4:40 PM EDT) -- Novartis Pharmaceuticals Corp. has struck a $2.75 million settlement with Kentucky over allegations that the drugmaker defrauded the state's Medicaid program by publishing false and inflated average wholesale prices for its drugs, the state's attorney general announced Wednesday.

The suit alleged that Novartis published false, inflated and deceptive AWPs — which the state's Medicaid program relies on to calculate drug reimbursement rates — for its products that had no ties to the real prices the company actually charged its customers, according to Attorney General Jack Conway,...
To view the full article, register now.